|
End-of-day quote
Korea S.E.
2026-05-08
|
5-day change
|
1st Jan Change
|
|
22,200.00 KRW
|
+1.14%
|
 |
-1.55%
|
+0.68%
|
|
03-09 |
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
11-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
|
CI
| |
11-05 |
Daewoong Co., Ltd. announces Annual dividend, payable on April 13, 2026
|
CI
| |
25-08-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
|
CI
| |
25-05-15 |
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
25-03-07 |
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
|
CI
| |
24-11-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
|
CI
| |
24-10-31 |
Daewoong Development Co. Ltd. announced that it expects to receive KRW 60 billion in funding from Daewoong Co., Ltd.
|
CI
| |
24-08-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
|
CI
| |
24-07-18 |
China suspends imports of Daewoong Bio's antibiotic over law violation
|
RE
| |
24-05-14 |
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| |
24-03-08 |
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
|
CI
| |
24-02-15 |
Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia
|
MT
| |
24-02-05 |
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
|
CI
| |
24-01-31 |
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
|
CI
| |
24-01-30 |
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.
|
CI
| |
23-12-11 |
Zydus Unit, Daewoong Pharma to Co-Develop, Commercialize Leuprolide Acetate in US
|
MT
| |
23-11-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
|
CI
| |
23-11-03 |
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
|
CI
| |
23-08-30 |
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia
|
MT
| |
23-08-14 |
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
|
CI
| |
23-08-02 |
Daewoong Pharmaceutical's Nabota Surpasses 600,000 Customers in the US
|
MT
| |
23-07-27 |
Daewoong Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.
|
CI
| |
23-07-26 |
Daewoong Co., Ltd. authorizes a Buyback Plan.
|
CI
| |
23-05-15 |
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
